Announcement on Change of Sponsor Representative for Continuous Supervision
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Change of Sponsor Representative for Continuous Supervision
Filed with SSE · · 2 pages · Chinese
Release
Aurisco Pharmaceutical Co. Ltd. on 6ix
Earlier from Aurisco Pharmaceutical
- Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
- Announcement on Redemption of Partial Idle Raised Funds Used for Cash Management upon Expiration and Continuously Conducting Cash Management
- Announcement on Convening the 2025 Semi-annual Performance Briefing
- Announcement on Shareholding Reduction Plan for Partial Senior Executives
- Announcement on Redemption upon Maturity of Partial Idle Raised Funds Used for Cash Management
Later from Aurisco Pharmaceutical
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
- Announcement on Achieving Conditions for Lifting Sales Restrictions and Listing of the 3rd Restricted Stock Trading Period under the 2022 Restricted Stock Incentive Plan
- Announcement on Shareholding Reduction Plan for Shareholders
- Announcement on Convening the Q3 2025 Performance Briefing
- Announcement on Obtaining Drug Registration Approval by the Wholly-owned Subsidiary
Follow Aurisco Pharmaceutical into a list and get an email when it puts out news.
Follow Aurisco Pharmaceutical